Welcome to Online Business Leads | MLM Lead Sources
Diabetic Lead Generation News
ChemoCentryx Announces Phase I Data With CCX507, Company's New Generation Orally Administered CCR9 Inhibitor
MOUNTAIN VIEW, Calif. and ORLANDO, Fla. -- ChemoCentryx, Inc. announced data showing that CCX507, a next generation orally available inhibitor of the chemokine receptor known as CCR9, exhibited excellent ...
Read more...NeuroMetrix Reports Q1 2013 Results
NeuroMetrix, Inc. , a medical device company focused on the treatment of diabetic peripheral neuropathy , today reported business and financial highlights for the first quarter ended March 31, 2013.
Read more...ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013
MOUNTAIN VIEW, Calif. -- ChemoCentryx, Inc. announced today its financial results for the first quarter ended March 31, 2013.
Read more...Deaths reported in kids taking 'newer generation' antipsychotics
Health Canada is receiving growing numbers of reports of serious complications in children taking powerful antipsychotics, including deaths. Once reserved for schizophrenia and mania in adults, the drugs are increasingly being prescribed to children as young as preschoolers. As of […]
Read more...Deaths reported in children prescribed 'newer generation' antipsychotics
Health Canada is receiving growing numbers of reports of serious complications in children taking powerful antipsychotics, including deaths.
Read more...